I cannot for the life of me see how ANYBODY can put a fundamental share value on MBP. It is all based on smoke and mirrors at the moment. They have not earned a cent, and as they cannot manufacture or distribute any of the drugs themselves, then any valuation of their shares HAS to take into account whatever deal they can do with a pharmaceutical major. To try and value their shares on anything else is pure guesswork and optimism.
That's why I think the Cohen report is pure ramping, nothing less.
I don't hold MBP.
- Forums
- ASX - By Stock
- MBP
- information on mbp-- see website:
information on mbp-- see website:, page-5
-
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MBP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online